Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1998 May;124(1):27–34. doi: 10.1038/sj.bjp.0701789

The role of tachykinin NK1 and NK2 receptors in atropine-resistant colonic propulsion in anaesthetized guinea-pigs

A Lecci 2,*, S Giuliani 1, M Tramontana 1, R D Giorgio 1, C A Maggi 1
PMCID: PMC1565351  PMID: 9630339

Abstract

  1. The role of endogenous tachykinins on guinea-pig colonic propulsion was investigated by using potent and selective tachykinin NK1 and NK2 receptor antagonists. Colonic propulsion and contractions were determined by means of a balloon-catheter device, inserted into the rectum of guanethidine (68 μmol kg−1, s.c., 18 and 2 h before)-pretreated, urethane-anaesthetized guinea-pigs. Propulsion of the device (dynamic model) was determined by measuring the length of the catheter expelled during 60 min filling of the balloon (flow rate 5 μl  min−1).

  2. In control conditions the tachykinin NK1 receptor antagonist SR 140333 (1 μmol kg−1, i.v.) did not affect either colonic propulsion or the amplitude of contractions. The tachykinin NK2 receptor antagonists MEN 10627 and MEN 11420 (1 μmol kg−1, i.v.) increased colonic propulsion at 10 min (+120% and 150%, respectively) but at 60 min the effect was significant only for MEN 10627 (+84%). SR 48968 (1 μmol kg−1, i.v.) did not significantly enhance the colonic propulsion. None of these tachykinin NK2 receptor antagonists modified the amplitude of colonic contractions. In contrast, both atropine (6 μmol kg−1, i.v., plus infusion of 1.8 μmol h−1) and hexamethonium (55 μmol kg−1, i.v., plus infusion of 17 μmol h−1) abolished propulsion (81% and 87% inhibition, respectively) and decreased the amplitude of contractions (68% inhibition for either treatment).

  3. In atropine-treated animals (6 μmol kg−1, i.v., plus infusion of 1.8 μmol h−1), apamin (30 nmol kg−1, i.v.) restored colonic propulsion (+416%) and increased the amplitude of contractions (+367% as compared to atropine alone). Hexamethonium (55 μmol kg−1, i.v., plus infusion of 17 μmol h−1) abolished the apamin-induced, atropine-resistant colonic propulsion (97% inhibition) and reduced the amplitude of the atropine-resistant contractions (52% inhibition).

  4. The apamin-induced, atropine-resistant colonic propulsion was inhibited by SR 140333 (−69% at 1 μmol kg−1), SR 48968 (−78% at 1 μmol kg−1), MEN 11420 (−59% at 1 μmol kg−1) and MEN 10627 (−50% at 1 μmol kg−1), although the latter effect was not statistically significant. The combined administration of SR 140,333 and MEN 10,627 (1 μmol kg−1 for each antagonist) almost completely abolished colonic propulsion (90% inhibition). The amplitude of colonic contractions was also reduced by SR 140333 (−42%), SR 48968 (−29%), MEN 11420 (−45%) but not by MEN 10627 (−16%). The combined administration of SR 140333 and MEN 10,627 reduced the amplitude of contractions by 47%. SR 140603 (1 μmol kg−1, i.v.), the less potent enantiomer of SR 140333, was inactive.

  5. In control animals, apamin (30 nmol kg−1, i.v.) enhanced colonic propulsion (+84%) and increased the amplitude of contractions (+68%), as compared to the vehicle. Hexamethonium (55 μmol kg−1, i.v. plus infusion of 17 μmol h−1) inhibited propulsion (86% inhibition) and decreased the amplitude of contractions (49% inhibition). SR 140333, SR 48968, MEN 11420, MEN 10627, or the coadministration of SR 140333 and MEN 10627 had no effect.

  6. In a separate series of experiments, the mean amplitude of colonic contractions was also recorded under isovolumetric conditions through the balloon-catheter device kept in place at 75 mm from the anal sphincter (static model). In control conditions, neither SR 140333 nor MEN 11420 modified the amplitude of contractions. In atropine-pretreated guinea-pigs, SR 140333 and MEN 11420 (0.1–1 μmol kg−1) dose-dependently decreased the amplitude of contractions. In apamin- and atropine-pretreated animals, only the highest (1 μmol kg−1) dose of SR 140333 or MEN 11420 significantly decreased the amplitude of contractions. The inhibitory potency of atropine (0.3–1 μmol kg−1) was similar in apamin-pretreated animals and in controls.

  7. It was concluded that, in anaesthetized guinea-pigs, endogenous tachykinins, acting through both NK1 and NK2 receptors, act as non-cholinergic excitatory neurotransmitters in promoting an apamin-evoked reflex propulsive activity of the distal colon.

Keywords: Apamin; atropine; colon; hexamethonium; MEN 10627; MEN 11420, SR 48968, peristalsis; SR 140333; tachykinin antagonists

Full Text

The Full Text of this article is available as a PDF (336.9 KB).


Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES